Cochlear | COH - Market Capitalization

Stock Price
95.25
Daily Change
-2.10 -2.16%
Monthly
-42.94%
Yearly
-64.51%
Q2 Forecast
95.52

Cochlear reported AUD6.37B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Ansell USD 3.36B 450.92M Dec/2025
Avita Medical AUD 105.47M 35.32M Dec/2025
Cochlear AUD 17.05B 2.6B Dec/2025
CSL USD 55.89B 20.42B Dec/2025
Fisher Paykel Healthcare NZD 21.76B 2.1B Dec/2025
Integral Diagnostics AUD 1.08B 457.31M Dec/2024
Mayne Pharma AUD 252.67M 153.55M Dec/2025
Mesoblast USD 2.3B 25.17M Apr/2026
Monash IVF AUD 286.38M 11.69M Dec/2025
Nanosonics AUD 1.2B 25.43M Dec/2025
Polynovo AUD 849.74M 24.18M Dec/2025
Ramsay Health Care AUD 7.93B 537.83M Dec/2025
Regis Healthcare AUD 2.1B 260.38M Dec/2025
ResMed USD 52.52B 12.57B Dec/2025
Sigma Healthcare AUD 2.7B 1.99B Apr/2026
Somnomed AUD 79.04M 27.72M Jun/2023
Sonic Healthcare AUD 11.17B 1.7B Dec/2025
Telix Pharmaceuticals AUD 5.07B 5.81B Dec/2025